Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience pipeline

Ad hoc announcement pursuant to Art. 53 LR Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseasesAdvances the Novartis ...

Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG

Avidity Biosciences, Inc. ("Avidity") (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA ...

‘The Bermuda Triangle of Talent’: 27-year-old Oxford grad turned down McKinsey and Morgan Stanley to find out why Gen Z’s smartest keep selling out

Simon van Teutem talked to Fortune about “the illusion of infinite choice, and the social status … You’re always looking for ...

Here’s how to ramp up India’s nuclear capacity

The national aim is to expand nuclear capacity 12-fold to 100 GW by 2047. It can’t happen with a business as usual approach.

Elder Gerrit W. Gong announces multifaith effort to evaluate how artificial intelligence treats religions

Religious leaders look forward to a robust computer science tool that will test how accurately and respectfully AI programs ...

How the new movement of RPCfi aims to revive DeFi yield

A new model channels RPC infrastructure spending into onchain liquidity and real yield, transforming costs into usage-driven ...